Making prevention pay

Funding for biodefense is spurring new vaccine and anti-infective programs at several biotech companies.

Detalles Bibliográficos
Autor principal: Dove, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097210/
https://www.ncbi.nlm.nih.gov/pubmed/15060549
http://dx.doi.org/10.1038/nbt0404-387
_version_ 1783510968932761600
author Dove, Alan
author_facet Dove, Alan
author_sort Dove, Alan
collection PubMed
description Funding for biodefense is spurring new vaccine and anti-infective programs at several biotech companies.
format Online
Article
Text
id pubmed-7097210
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-70972102020-03-26 Making prevention pay Dove, Alan Nat Biotechnol Article Funding for biodefense is spurring new vaccine and anti-infective programs at several biotech companies. Nature Publishing Group US 2004 /pmc/articles/PMC7097210/ /pubmed/15060549 http://dx.doi.org/10.1038/nbt0404-387 Text en © Nature Publishing Group 2004 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Dove, Alan
Making prevention pay
title Making prevention pay
title_full Making prevention pay
title_fullStr Making prevention pay
title_full_unstemmed Making prevention pay
title_short Making prevention pay
title_sort making prevention pay
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097210/
https://www.ncbi.nlm.nih.gov/pubmed/15060549
http://dx.doi.org/10.1038/nbt0404-387
work_keys_str_mv AT dovealan makingpreventionpay

Ejemplares similares